Israel - hebreu - Ministry of Health

beit-erez havat milatin ltd - ivermectin 10 mg/ml - solution for injection - treatment of stomach and intestinal rounoworm infestations in cattle.

Israel - hebreu - Ministry of Health

beit-erez havat milatin ltd - spiramycin 60 miu / 100 ml - solution for injection - for treatment of upper respiratory disease in the dry season for infections sensitive to spiramycin in cattle and sheep only.

Israel - hebreu - Ministry of Health

beit-erez havat milatin ltd - spiramycin - תמיסה להזרקה - spiramycin 600000 iu/ml

Israel - hebreu - Ministry of Health

כמיפל בעמ - טיפוח הקרקפת עור יבש

Israel - hebreu - Ministry of Health

ה.א.פרו בע"מ - רופא שיניים - מדריך כירורגי דנטאלי עבור שתלים

Israel - hebreu - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii

Israel - hebreu - Ministry of Health

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - אבקה וממס להכנת תמיסה להזרקה - von willebrand factor 500 iu/vial; factor viii (human) 500 iu/vial - coagulation factor viii

Israel - hebreu - Ministry of Health

abic veterinary products ltd - sulphadiazine; trimethoprim - אבקה - sulphadiazine 250 mg/g; trimethoprim 50 mg/g

Israel - hebreu - Ministry of Health

abic veterinary products ltd - sulfadiazine sodium; trimethoprim - תמיסה (פומי) - trimethoprim 16 mg/ml; sulfadiazine sodium 86.4 mg/ml

Israel - hebreu - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.